MedTrace Logo

Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.

NCT04388631 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-05-18

No results posted yet for this study

Summary

This study will evaluate the changes in sexual function, reproductive function and mental health of male patients discharged from the hospital with COVID-19, and the impact of SARS-CoV-2 on male reproductive health and mental health compared with healthy people during the same period. In addition, men's semen examination reports before and after the new coronavirus pneumonia event will be collected and compared to assess the impact of the event on the quality of men's semen. Also, This study will test the SARS-CoV-2 nucleic acid of the urogenital system of male patients discharged with COVID-19 to provide evidence for the effect of the new coronavirus on the male reproductive system.

Conditions

  • Coronavirus Disease 2019

Interventions

OTHER

Coronavirus Disease 2019

male patients who have developed COVID-19

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Jihong Liu, M.D · Departments of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-10
Primary Completion
2021-05-01
Completion
2021-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04388631 on ClinicalTrials.gov